Related by context. All words. (Click for frequent words.) 79 Results Indicate 77 Delineates 77 Successfully Completed 77 Provides Clarification 76 Near Surface 76 Drilling Confirms 75 Provides Update Regarding 74 Trenching Results 74 Study Indicates 74 Drilling Intersects 74 Significantly Increases 74 Assay Results From 74 Targets Identified 74 Confirms Significant 74 Reduces Risk 74 Provides Updates 74 Shows Promising 73 Lupus Drug 73 Crowflight Announces 73 Helps Identify 73 Correlation Between 73 Receives Positive 73 XPEL Announces 73 Pacific Rubiales Announces 73 Improves Survival 73 Report Indicates 73 Drilling Intercepts 73 Macusani Yellowcake Announces 73 Helps Predict 73 Drilling Extends 73 Announce Commencement 72 Completes Initial 72 Data Suggest 72 Re Affirms 72 Significant Increase 72 Issues Clarification 72 Study Demonstrates 72 Copper Mineralization 72 Moves Towards 72 Jointly Announce 72 Study Analyzes 72 Substantial Increase 72 Achieves Milestone 72 BIOLASE Announces 72 Files Patent Application 72 High Grade Intercepts 72 Signs Option Agreement 72 Significantly Expands 72 Further Validates 72 Identifies Potential 71 Drill Hole Results 71 Shows Promise 71 Immunomedics Announces 71 Dramatically Increases 71 Successfully Tests 71 Demonstrates Positive 71 Announces Successful Completion 71 Univest Corporation Declares 71 Drilling Underway 71 Flamel Technologies Announces 71 Receives Permit 71 Summarizes 71 Validates 71 Completes Successful 71 Reports Positive 71 Receives Conditional Approval 71 Amplifies 71 Randomized Trials 71 FDA Clears 71 Drilling Continues 71 Study Confirms 71 Doubles Capacity 71 Proves Successful 71 Successfully Completes 71 Data Indicates 71 Could Trigger 71 Updates Status 70 Confirms Efficacy 70 Oroco Announces 70 Announces Initiation 70 Significantly Expand 70 Final Stages 70 Verifies 70 Clinical Trial Results 70 Study Shows Benefits 70 Commercializes 70 Announces Positive 70 Silver Mineralization 70 Drug Candidate 70 Achieves Positive 70 Strengthens Balance Sheet 70 Receives Favorable 70 Bodes Well 70 Announce Completion 70 Test Detects 70 Medicure Announces 70 Commences Phase 70 KEMET Announces 70 Awarded Patent 70 PPD Declares 70 Resumes Drilling 70 Newly Identified 70 Naturally Occurring 70 Merge Healthcare Announces 70 Excellon Announces 70 Provides Clues 70 Milestone Achieved 70 Successful Completion 70 Undertakes 70 Successfully Complete 70 Statistically Significant 70 Evaporates 70 Receives Notification 70 Helps Ensure 70 Updates Shareholders 70 Identifies Key 70 Nicotine Vaccine 70 Temporarily Suspends 70 Help Detect 70 Collaborators Present 70 Underscores Importance 70 ANADIGICS Announces 70 Holds Promise 70 Completes Patient Enrollment 70 Mechel Announces 70 Circulating Tumor Cells 70 Report Suggests 70 Provides Comprehensive 70 Successfully Concludes 70 Cites Positive 70 Reveals Significant 70 Study Validates 70 MAG Silver Reports 70 Announces Effective Date 70 Fortifies 70 Delivers Unprecedented 70 Provides Detailed 70 Announces Publication 70 Private Placement Closed 69 Report Assesses 69 Identifies Significant 69 Provides Shareholder 69 Significantly Improves 69 Be Evaluated 69 Tests Reveal 69 Surface Sampling 69 Terminates Contract 69 Infill Drilling 69 Commence Immediately 69 Achieves Significant 69 Assay Results 69 Improves Outcomes 69 SABESP Announces 69 Study Proves 69 Metallurgical Testing 69 Clarifies Status 69 Inter Citic Reports 69 Could Predict 69 Awarded Patents 69 Confirms Presence 69 Diagnostic Tests 69 Momentum Builds 69 Completes Expansion 69 Has Received 69 Drill Targets 69 Issues Guidance 69 Poniard Pharmaceuticals Announces 69 Contracts Awarded 69 Board Authorizes 69 Report Identifies 69 Receives Patent 69 Has Commenced 69 Provides Operational Update 69 Kaydon Corporation Announces 69 Spectrum Pharmaceuticals Announces 69 AnaSpec Introduces 69 Finalizes Agreement 69 Drilling Completed 69 Completes Enrollment 69 Bulk Sampling Program 69 Expands Scope 69 Attains 69 Warrants Exercised 69 Forges Ahead 69 Announcement Regarding 69 Being Evaluated 69 Exceeds Expectations 69 Significantly Reduces 69 StockSource.us Reports 69 Formalizes 69 Positive Scoping Study 69 Exercises Option 69 Inter Citic Releases 69 Study Shows Significant 69 Demonstrates Significant 69 Initiates Drilling 69 Reconfirms 69 Being Studied 69 Report Examines 69 Significantly Improved 69 Miraculins Announces 69 Announces Signing 69 Receives Positive Results 69 Guidelines Issued 69 Completes Drilling 69 Announce Successful Completion 69 Provides Guidance 69 Dia Bras Announces 69 Radiation Exposure 69 Announces Termination 69 Continues Momentum 69 Completes Second Tranche 69 Survival Benefit 69 La Mina Porphyry 69 Announces FDA Clearance 69 AVI BioPharma Announces 68 Becomes Effective 68 Results Exceed Expectations 68 &Amp; 68 Affirms Commitment 68 Gold Intercepts 68 Study Identifies 68 Highlights Importance 68 Clears Path 68 Announces Favorable 68 Technological Advances 68 Report Analyzes 68 Study Casts Doubt 68 Enters Negotiations 68 Appears Safe 68 Reduces Cost 68 Confirms Continuity 68 Concerns Remain 68 Gene Variation 68 Study Recommends 68 Announces Assay Results 68 What Constitutes 68 Drug Fails 68 Distinguishes 68 Study Reinforces 68 Receives Confirmation 68 Bush Embraces Pause 68 Proven Effective 68 Potentially Fatal 68 Closes Financing 68 Sees Positive 68 Discontinues 68 Gene Variants 68 Expand Scope 68 Milestone Reached 68 Announces Cancellation 68 Finalises 68 Momentum Continues 68 Reduces Debt 68 Improves Accuracy 68 Arranges Private Placement 68 Platform Enables 68 Additional Assay Results 68 Completes Transition 68 Genetic Defect 68 ESCO Announces 68 Has Achieved 68 Announces Non Brokered 68 Useful Tool 68 Gene Variant 68 Provides Unprecedented 68 Receives Conditional 68 Preclinical Data 68 Releases Second Quarter 68 Measurement Specialties Announces 68 Fifth Consecutive 68 Grants Options 68 Dramatically Expands 68 Pending Acquisition 68 Announces Resumption 68 Recommences 68 Underlies 68 Expert Discusses 68 Announces Debt Settlement 68 Less Invasive 68 Receives FDA Clearance 68 Helps Detect 68 Report Sheds Light 68 Initiates Clinical Trial 68 Trend Continues 68 Various Types 68 Accelerate Adoption 68 Survey Identifies 68 Medoro Resources Announces 68 Closes Private Placements 68 Greystar Resources Announces 68 Review Initiated 68 Submits Application 68 Updates Guidance 68 Maintains Strong 68 TriCo Bancshares Announces 68 FDA Okays 68 Genetic Tests 68 Report Cites 68 Hematological Cancers 68 Retracts 68 Expands Capabilities 68 Could Revolutionize 68 Stockholder Vote 68 Positive Results 68 Diversifies 68 Demonstrates Potential 68 Previously Announced 68 Deaths Prompt 68 Margin Expansion 68 Secures Financing 68 GeoMet Announces 68 Schweitzer Mauduit Announces 68 Successfully Demonstrates 68 Strongly Linked 68 Chart Presentation 68 Successfully Passes 68 Consummates 68 Extends Term 68 Nears Completion 68 Gene Mutation 68 Underpin 68 Emphasizes Need 68 Remains Intact 68 Strengthens Leadership 68 Further Strengthens 68 NYMH Announces 68 Increases Ownership 68 Trend Toward 68 Monetizes 68 Announces Stockholder Approval 68 Combination Treatment 68 -Wauk 68 Starts Drilling 67 ROCA Reports 67 Impairs 67 NMDA Receptor 67 Breast Cancer Recurrence 67 Effectively Treats 67 Has Entered 67 Drilling Has Commenced 67 Extends Offer 67 Stays Strong 67 Reclassifies 67 Refines 67 Prostate Cancer Diagnosis 67 Prolongs 67 Could Pave Way 67 Presents Positive 67 Expand Collaboration 67 Announce Receipt 67 Generates Record 67 Bulk Tonnage 67 Sees Continued 67 Reports Assay Results 67 Solution Delivers 67 Receives Certification 67 Unfractionated Heparin 67 Closes Previously Announced 67 Phase 2b Clinical Trial 67 Drilling Resumes 67 Be Studied 67 Meets Primary Endpoint 67 Patients Undergoing 67 Retains Investor Relations 67 Makes Significant 67 Lowers Risk 67 Quadruples 67 Antiviral Drugs 67 Publishes Updated 67 Sniffs Out 67 Restricts Access 67 Shows Promise Against 67 Reactivates 67 Gathers Steam 67 Board Unanimously Rejects 67 Vicor Technologies Announces 67 Proves Effective 67 Drill Intercepts 67 BayStreet.ca Research Alert 67 Announces Preliminary 67 Increases Risk 67 Formally Launches 67 Portend 67 Novel Method 67 Boosts Productivity 67 Present Preclinical Data 67 Refocuses 67 Challenges Loom 67 Uncertainty Surrounds 67 Enables Rapid 67 Data Indicate 67 Prostate Cancer Patients 67 Delivers Breakthrough 67 Prognostic Value 67 Prostate Tumors 67 Exploratory Drilling 67 Provide Comprehensive 67 Obtains Financing 67 Adjuvant Chemotherapy 67 Commence Drilling 67 Achieves Highest 67 Hepatitis C Treatment 67 Evidence Suggests 67 Announces Granting 67 Files IND 67 Underground Sampling 67 Engages Investor Relations 67 Can Predict 67 Effort Fails 67 Releases Findings 67 Tumor Cells 67 Migraine Drug 67 Study Concludes 67 Subsidiary Receives 67 Closes Private Placement 67 Drilling Commences 67 Announce Collaboration Agreement 67 Antibiotic Use 67 Researchers Uncover 67 Predictive Value 67 Announces Immediate Availability 67 Caution Urged 67 Closes Acquisition 67 Hormonal Therapy 67 Patient Enrollment 67 Provides Valuable 67 Commence Production 67 Previously Announced Private Placement 67 Pave Way 67 Initial Assay Results 67 Mobilizes Drill 67 Prolongs Survival 67 ViRexx Announces 67 Subsidiary Enters 67 Gastar Exploration Announces 67 Successfully Tested 67 Announces Successful 67 Seeks Approval 67 NDA Submission 67 Renal Tumors 67 Nine Month 67 Help Diagnose 67 Significant Reduction 67 Completes Private Placement 67 Announces Commencement 67 Drug Combo 67 Concerns Raised 67 Reveals Secrets 67 Announces Ticker Symbol 67 Has Been Completed 67 Reprices 67 Shows Efficacy 67 Delivers Next Generation 67 Reduces Size 67 Likely Delayed 67 Levels Linked 67 Flu Strains 67 Introduces Unique 67 Introduces Next Generation 67 Mineralized Zones 67 FDA Approvals 67 Antibiotic Treatment 67 Furthers 67 Results Reflect 67 Higher Than Expected 67 Improves Quality 67 Momentum Grows 67 Releases Third Quarter 67 Progresses 67 Commences Drilling 67 Enters Into Negotiations 67 Aggressive Prostate Cancer 67 Receives Orphan Drug Designation 67 Eradicates 67 Study Pinpoints 67 Questions Arise 67 Genes Linked 67 Provides Operational 67 Key Milestones 67 Epilepsy Drug 67 Unsolicited Tender Offer 67 Gain Traction 67 Detect Cancer 67 Provides Update 67 Anounces 67 Seeks Delay 67 Mineralization Extended 67 Enlarges 67 Could Save Lives 67 Could Complicate 67 Genes Associated 67 Complete Merger 67 Findings Reveal 67 Releases Next Generation 67 Begins Drilling 67 Announce Formation 67 Announces Dismissal 67 Uranium Mineralization 67 Stereotaxis Announces 67 Therapeutic Antibody 67 Makes Headway 67 Equity Funds Declare 67 Transplant Patients 67 Completes Financing 67 Commences Drill Program 67 Chalks Up 67 InterOil Announces 67 Receives Milestone Payment 67 Releases Latest 67 Provides Updated 67 Help Predict 67 Ticks Higher 67 Statin Drugs 67 Clinical Trial Data 67 Study Sheds Light 67 Drill Intersections 67 Significant Improvements 67 Sign License Agreement 67 ISSI Announces 67 Closes Second Tranche 67 Offers Clues 67 Experts Advise 67 Localized Prostate Cancer 67 Expert Predicts 66 Underlie 66 Amend Merger Agreement 66 Lay Groundwork 66 Mad Cow Testing 66 Receives Notice 66 Discloses 66 Gene Linked 66 Announce Merger Agreement 66 Be Examined 66 Commences Exploration 66 Confirms 66 Most Widely Used 66 Million Ounces Gold 66 Wizzard Software Announces 66 Alert Technicals Showing Bearish 66 Dramatic Increase 66 Underscores Need 66 Few Surprises 66 Improve Survival 66 Reports Significantly Improved 66 Provide Unprecedented 66 Flexpoint Announces 66 More Than Doubled 66 Lung Cancer Drug 66 Proves Elusive 66 Palladon Announces 66 Smartstox.com Spotlights 66 Eliminates Need 66 Introduces Breakthrough 66 Gold Intersected 66 Could Hinder 66 Extends Mineralization 66 Detecting Breast Cancer 66 Imaging Techniques 66 Positive Metallurgical 66 Announcement acc 66 Increases Private Placement 66 Anti Tumor Activity 66 Underpins 66 Witnesses Testify 66 Hold Clues 66 Could Endanger 66 Enters Into Agreement 66 Improve Accuracy 66 EPA Proposes 66 Tremendous Growth 66 Pre Cancerous 66 Concerns Arise 66 Poses Challenges 66 Q2 Loss Widens 66 Talks Underway 66 Questions Remain About 66 Consolidation Continues 66 Unveils Expanded 66 Q3 Loss Widens 66 Panel Recommends 66 Clinical Outcome 66 Important Milestone 66 Recommence 66 Restate Financial 66 Neoadjuvant Chemotherapy 66 Builds Momentum 66 Submits Proposal 66 Drill Assays 66 Previously Disclosed 66 Adtegrity.com Reports 66 Patented Technology 66 Could Prevent 66 Amends Agreement 66 Announces Completion 66 Nanophase Announces 66 Taro Receives 66 Can Be Avoided 66 Achieves Unprecedented 66 Could Backfire 66 Submits NDA 66 Projected Release Date 66 Patents Issued 66 Draws Mixed Reaction 66 Smallpox Vaccine 66 Chemotherapy Improves 66 Raises Fears 66 PremierWest Bancorp Announces 66 Commences Drilling Program 66 Newmont Declares Regular 66 Commences Initial 66 Martian Soil 66 Spins Off 66 Yields Clues 66 Addresses Growing 66 Obese Patients 66 Dividend Announcement 66 Provides Status 66 Gold Mineralization 66 Develops Novel 66 ARRIS Announces 66 Strike Length 66 Blood Clotting 66 Powerful Tool 66 Studies Suggest 66 LightPath Technologies Announces 66 Helps Improve 66 Chemotherapy Regimen 66 Study Assesses 66 Mobilises 66 Q3 Loss Narrows 66 Achieves Record 66 Oceaneering Announces 66 Anticipates Record 66 Reinforces 66 Presents Preclinical Data 66 Unsolicited Proposal From 66 Stabilizes 66 Demonstrate Interoperability 66 Could Detect 66 Highly Accurate 66 Substantially Increases 66 Announce Shareholder Approval 66 Growing Importance 66 FDA Panel Recommends 66 Predict Prostate Cancer 66 Revenues Increase 66 Spin Offs 66 Study Evaluates 66 Completes Integration 66 Forecast Predicts 66 Lays Groundwork 66 Net Loss Narrows 66 PDL BioPharma Announces 66 Sign Definitive Agreement 66 JDSU Introduces 66 First BanCorp Announces 66 Drug Shows Promise 66 Adjuvant Therapy 66 Contrast Agents 66 Files Patent 66 Spins Out 66 Awarded Contracts 66 Preliminary Metallurgical 66 Genetic Mutation 66 Remains Unchanged 66 Makes Strides 66 GRAS Status 66 Immune Cell 66 Scientists Warn 66 Has Been Announced 66 FY# Loss Widens 66 Adds Depth 66 Study Compares 66 Drilling Permit 66 Invoke Fifth Amendment 66 Demonstrates Commitment 66 IIROC Resume 66 Causing Concern 66 Profitable Quarter 66 KB Home Swings 66 Officially Confirmed 66 Slight Improvement 66 Introduces Enhanced 66 Study Predicts 66 Regains NASDAQ 66 Demands Immediate 66 2nd Quarter Results 66 Gains Momentum 66 Cardiogenic Shock 66 Q2 Loss Narrows 66 Enters Into Exclusive 66 Announces Availability 66 Initial Resource Estimate 66 Estrogen Therapy 66 Concerns Prompt 66 Adverse Outcomes 66 Dramatically Reduce 66 Gets Thumbs Down 66 Urine Test 66 Secures Patent 66 Receives Unsolicited 66 Remains Positive 66 Deepens 66 Advisers Urge 66 Provide Seamless 66 Files NI #-# 66 Shifts Toward 66 Report Reveals 66 Quaterra Announces 66 Emphasizes Importance 66 Achieves Record Sales 66 3rd Quarter Results 66 Vastly Different 66 Problems Remain 66 Customer Deployments 66 Flagstone Re Announces 66 Can Detect 66 Risks Remain 66 Violated Rules 66 Has Resumed 66 Demystifies 66 Develop Innovative 66 Has Been Awarded 66 Grade Mineralization 66 Verena Minerals Announces 66 Investors Await 66 Subsidiary Enters Into 66 Confirmatory 66 Predict Risk 66 Aethlon Medical Releases 66 Enables Faster 66 Revenues Decline 66 Well Positioned 66 Announce Availability 66 Awarded GSA 66 Strengthens Its 66 Cuts Costs 66 Insights Into 66 Contract Signings 66 Achieves ISO #:# Certification [002] 66 Acquire Assets 66 Deliver Powerful 66 Techni lab 66 Unveils Next Generation 66 Raises Concerns 66 Study Underscores 66 Pinpoints 66 Stock Soars 66 Q4 Loss Widens 66 Announces Operational Update 66 Protein Involved 66 Pinpointed 66 Third Consecutive 66 Issues Surrounding 66 Dramatically Reduces 66 Perform Poorly 66 Treatment Reduces 66 Could Undermine 66 Causes Concern 66 Aura Minerals Announces 66 Fourth Consecutive 66 Host Teleconference 66 Study Examines 66 Highly Prospective 66 Implant Sciences Announces 66 Attracts Attention 66 Problems Persist 66 Completes Installation 66 Achieves ISO # 66 Acquires Controlling Interest 66 To Length Au 66 Shareholders Approve Acquisition 66 Achieves Cisco 66 Trial Evaluating 66 Significantly Improve 66 Significantly Reduce 66 Accelerate Commercialization 66 Achieves Record Production 66 Annouces 66 Minera IRL Announces 66 Asthma Treatment 66 Initiates Enrollment 66 Demonstrates Ability 66 Substantially Reduce 66 BRE Properties Announces 66 Dramatically Improves 65 Achieve Significant 65 Files Amended 65 Apfn 65 Long Term Outcomes 65 Prognostic Significance 65 Jointly Develop 65 Raises Hopes 65 Demonstrates Improved 65 Productivity Gains 65 Finds Evidence 65 Repositions 65 Shares Soar 65 Enable Faster 65 Increases Size 65 Outlines Strategy 65 Tests Confirm 65 Lowers Costs 65 Losses Narrow 65 WGNB Corp. Announces 65 Fully Prepared 65 Anti Tumor 65 Metres Grading 65 Prostate Cancer Vaccine 65 Raser Technologies Announces 65 Negates 65 Prompts Questions 65 Successfully Completes Phase 65 Elevated Levels 65 Drill Results 65 Trading Halt 65 Hemodialysis Patients 65 Endometrial Cancer 65 Antidepressant Treatment 65 Gout Drug 65 Geokinetics Announces 65 Withdraws Proposal 65 Drill Holes 65 Drug Coated Stents 65 Study Showed 65 Accelr8 Announces 65 Reminds Shareholders 65 Offers Unprecedented 65 EntreMed Presents 65 Cast Doubt 65 Announces Expanded 65 Multiplies 65 Faces Setback 65 Announces Enhancements 65 Sees Significant 65 Develops Innovative 65 Boss Defends 65 Receives Orphan Drug 65 Expand Relationship 65 Oral Calcitonin 65 Retains Leading 65 Carries Out 65 Helps Reduce 65 Restructures Debt 65 Imaging Technique 65 Ramping Up 65 Thyroid Function 65 STERIS Corporation Announces 65 Enters Into Definitive Agreement 65 Be Tested 65 Announces Revised 65 Clarification Regarding 65 Protein Biomarker 65 Tonnes Ni 65 Ballot Count 65 Step Toward 65 Closes Oversubscribed 65 Gathers Momentum 65 Demonstrated Significant 65 Announces Filing 65 Announce License Agreement 65 Reveals 65 Prompts Changes 65 Gaps Remain 65 Drilling Update 65 Confirms Receipt 65 Funds Announce 65 Testing Capabilities 65 Minimal Impact 65 Misonix Announces 65 Unveils Groundbreaking 65 Method Developed 65 Sees Opportunity 65 Subsidiary Signs 65 TOFUTTI Announces 65 Epilepsy Drugs 65 Million Ounces 65 Concludes Successful 65 Cholesterol Lowering Drug 65 Researchers Identify 65 Begins Shipment 65 Investigational Agent 65 Focuses Attention 65 Growth Spurt 65 Completes Previously Announced 65 Develop Next Generation 65 -Vir ginia 65 Osteoporosis Treatment 65 Demonstrates Efficacy 65 Effort Needed 65 Announces Shareholder Approval 65 Daytradersdigest.com 65 Q1 Loss Narrows 65 Secures Funding 65 Remains Critical 65 Induces 65 Questions Linger 65 Osteoarthritis Pain 65 Scientists Unravel 65 Teva Provides Update 65 Shareholder Opinions 65 Jointly Offer 65 Amends Terms 65 Growing Rapidly 65 Presses Ahead 65 Taping Results SPOILERS 65 Guidance Quick Facts 65 Exercises Warrants 65 Achieves Certification 65 Delivers Strong 65 Successful Implementation 65 First Patient Treated 65 Terminate Merger 65 L.P. Announces 65 Anticancer Activity 65 Record Levels 65 Announce Settlement 65 FCC Approves 65 Wins Approval 65 CGGVeritas Announces 65 Drill Rigs 65 Protects Against 65 Receives CE Marking 65 Vaccine Prevents 65 Raises Questions 65 Pushes Ahead 65 Remains Steady 65 Joins OTCQX 65 Comet Dust 65 Ducommun Incorporated Announces 65 Halts Production 65 Versus Majors 65 Cause Concern 65 Grams Per Tonne 65 Underscore Need 65 Faces Hurdles 65 Fungal Infections 65 Decision Delayed 65 Spells Out 65 Jumps Higher 65 Questions Loom 65 Being Readied 65 Permit Approval 65 Study Evaluating 65 Osteoporosis Drug 65 Therapy Improves 65 -#:# GMT/# 65 Viable Alternative 65 Arthritis Drug 65 Resubmit 65 Resubmits 65 Virco Announces 65 Expectant Moms 65 Three Pronged 65 Reports Indicate 65 Minimally Invasive Treatment 65 Exploration Drilling 65 Looks Ahead 65 Jointly Developed 65 Protein Synthesis 65 VIVUS Announces 65 Announces Profitable 65 Unearths 65 Concerns Persist 65 Restates 65 Announces Organizational Changes 65 Acquire Controlling Interest 65 Bancolombia SA Announces 65 Breast Cancer Stem Cells 65 Announces Receipt 65 Net Loss Widens 65 Sharpens Focus 65 Surpasses Expectations 65 Helps Prevent 65 Patents Covering 65 Outlines Steps 65 Posts Strong 65 Bacterial Infection 65 Announces Private Placement 65 Shifts Focus 65 Raises Doubts About 65 Dips Slightly 65 Settles Litigation 65 Record Third Quarter 65 Length m 65 Announce Filing 65 Introduces Revolutionary 65 Rheumatoid Arthritis Patients 65 Outperforms 65 Feds Approve 65 Refile 65 Widens Quick Facts 65 Improve Quality 65 Osteoporosis Drugs 65 Increases Productivity 65 Statement Regarding 65 Anticipates 65 SulphCo Announces